Medicus Pharma Ltd. Common Stock MDCX Open Medicus Pharma Ltd. Common Stock in new tab
Medicus Pharma Ltd. Common Stock Analysis (MDCX)
Is Medicus Pharma Ltd. Common Stock a good investment? Medicus Pharma Ltd. Common Stock (MDCX) is currently trading at 0.2911 USD. Market analysts have a consensus price target of 6.50 USD. This suggests a potential upside from current levels.
Earnings Schedule: Medicus Pharma Ltd. Common Stock is expected to release its next earnings report on Aug. 10, 2026. The market consensus estimate for Forward EPS is -0.41.
Investor FAQ
Does Medicus Pharma Ltd. Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is Medicus Pharma Ltd. Common Stock?
Medicus Pharma Ltd. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Aug. 10, 2026. The company currently has a trailing EPS of -2.74.
Company Profile
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
Dividends
Historical Split Corporate Actions
Explore Premium Features
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion